Nocturne
Well-known member
www.lipid.org/sites/default/files/12-moriarty.pdf
What I am seeing here makes it seem criminal that we are not offering apheresis treatments to people with heart disease and extremely high Lp(a) in the USA. Read about a reduction in event rates of between 80-90% after initiating apheresis treatments. And that is after LDL reduction from statin is taken into consideration!
And our docs tell us that the best they can do is to lower our LDL cholesterol with statins?
They are LYING to us!
I realize that this may not seem relevant to everyone here, but remember that Lp(a) is a significant risk factor for CAVS -- and that probably applies to people with BAV as well! Remember that many people with BAV never develop AVS; how many of the ones that do also have high Lp(a)? How many of them would not have developed AVS if their Lp(a) had been brought down before they did?
What I am seeing here makes it seem criminal that we are not offering apheresis treatments to people with heart disease and extremely high Lp(a) in the USA. Read about a reduction in event rates of between 80-90% after initiating apheresis treatments. And that is after LDL reduction from statin is taken into consideration!
And our docs tell us that the best they can do is to lower our LDL cholesterol with statins?
They are LYING to us!
I realize that this may not seem relevant to everyone here, but remember that Lp(a) is a significant risk factor for CAVS -- and that probably applies to people with BAV as well! Remember that many people with BAV never develop AVS; how many of the ones that do also have high Lp(a)? How many of them would not have developed AVS if their Lp(a) had been brought down before they did?
